|
Volumn 26, Issue 7, 2003, Pages 2032-2036
|
Evaluating concordance to American Diabetes Association standards of care for type 2 diabetes through group visits in an uninsured or inadequately insured patient population
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALBUMIN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTILIPEMIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HEMOGLOBIN A1C;
GLYCOSYLATED HEMOGLOBIN;
LIPID;
ARTICLE;
CONTROLLED STUDY;
DRUG USE;
EVALUATION;
HEALTH CARE DELIVERY;
HEALTH INSURANCE;
HEALTH SERVICE;
HEMOGLOBIN DETERMINATION;
HUMAN;
INFLUENZA VACCINATION;
MAJOR CLINICAL STUDY;
MANAGED CARE;
MEDICAL SOCIETY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT CARE;
PATIENT REFERRAL;
PROTEIN URINE LEVEL;
RETINA EXAMINATION;
STANDARD;
ADULT;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
FEMALE;
FOLLOW UP;
HEALTH CARE QUALITY;
MALE;
MIDDLE AGED;
PATIENT;
RACE;
RANDOMIZED CONTROLLED TRIAL;
SOCIOECONOMICS;
STATISTICS;
TIME;
UNITED STATES;
ADULT;
CONTINENTAL POPULATION GROUPS;
DELIVERY OF HEALTH CARE;
DIABETES MELLITUS, TYPE 2;
FEMALE;
FOLLOW-UP STUDIES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
LIPIDS;
MALE;
MEDICALLY UNINSURED;
MIDDLE AGED;
QUALITY ASSURANCE, HEALTH CARE;
SOCIETIES, MEDICAL;
SOCIOECONOMIC FACTORS;
TIME FACTORS;
UNITED STATES;
|
EID: 2142718433
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.26.7.2032 Document Type: Article |
Times cited : (54)
|
References (5)
|